![David Karpf](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Karpf
Corporate Officer/Principal presso Stanford University School of Medicine
Posizioni attive di David Karpf
Società | Posizione | Inizio | Fine |
---|---|---|---|
Stanford University School of Medicine | Corporate Officer/Principal | - | - |
Storia della carriera di David Karpf
Precedenti posizioni note di David Karpf
Società | Posizione | Inizio | Fine |
---|---|---|---|
LUMOS PHARMA, INC. | Direttore Tecnico/Scientifico/R&S | 03/08/2021 | 29/06/2023 |
Merck Research Laboratories Massachusetts LLC
![]() Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Direttore Tecnico/Scientifico/R&S | 01/01/1991 | 01/01/1996 |
Stanford Health Care
![]() Stanford Health Care Hospital/Nursing ManagementHealth Services Stanford Health Care provides healthcare services. It services includes cardiac care, cancer treatment, neurosciences, surgery and organ transplants. The company was founded in 1956 and is headquartered in Stanford, CA. | Corporate Officer/Principal | - | - |
Roche Global Development | Direttore Tecnico/Scientifico/R&S | - | - |
Virobay, Inc.
![]() Virobay, Inc. Pharmaceuticals: MajorHealth Technology Virobay, Inc. develops protease inhibitors for the treatment of neuropathic pain, cancer, autoimmune and liver diseases. It utilize cysteine cathepsin platform for the development and commercialization of novel drugs. The firm's research & development activities focuses on neuropathic pain, autoimmune diseases and liver fibrosis. The company was founded by Robert F. G. Booth on May 18, 2006 and is headquartered in Menlo Park, CA. | Direttore Tecnico/Scientifico/R&S | 03/11/2011 | - |
Calydon, Inc.
![]() Calydon, Inc. Medical SpecialtiesHealth Technology Part of ANI Pharmaceuticals, Inc., Calydon, Inc. develops therapeutic products for cancer. The company is based in Sunnyvale, CA. Calydon was acquired by Cell Genesys, Inc. on September 05, 2001 for $17.68 million. | Direttore Tecnico/Scientifico/R&S | - | - |
Consigliere Generale | - | - | |
GERON CORPORATION | Direttore Tecnico/Scientifico/R&S | 10/06/2009 | - |
Corporate Officer/Principal | 01/01/2001 | 10/06/2009 | |
CYMABAY THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2004 | - |
Formazione di David Karpf
University of California, Berkeley | Undergraduate Degree |
University of California San Diego | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 12 |
Posizioni
Chief Tech/Sci/R&D Officer | 7 |
Corporate Officer/Principal | 3 |
Doctorate Degree | 1 |
Settori
Health Technology | 7 |
Consumer Services | 4 |
Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
GERON CORPORATION | Health Technology |
LUMOS PHARMA, INC. | Health Technology |
Aziende private | 6 |
---|---|
CymaBay Therapeutics, Inc.
![]() CymaBay Therapeutics, Inc. BiotechnologyHealth Technology CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA. | Health Technology |
Virobay, Inc.
![]() Virobay, Inc. Pharmaceuticals: MajorHealth Technology Virobay, Inc. develops protease inhibitors for the treatment of neuropathic pain, cancer, autoimmune and liver diseases. It utilize cysteine cathepsin platform for the development and commercialization of novel drugs. The firm's research & development activities focuses on neuropathic pain, autoimmune diseases and liver fibrosis. The company was founded by Robert F. G. Booth on May 18, 2006 and is headquartered in Menlo Park, CA. | Health Technology |
Calydon, Inc.
![]() Calydon, Inc. Medical SpecialtiesHealth Technology Part of ANI Pharmaceuticals, Inc., Calydon, Inc. develops therapeutic products for cancer. The company is based in Sunnyvale, CA. Calydon was acquired by Cell Genesys, Inc. on September 05, 2001 for $17.68 million. | Health Technology |
Stanford Health Care
![]() Stanford Health Care Hospital/Nursing ManagementHealth Services Stanford Health Care provides healthcare services. It services includes cardiac care, cancer treatment, neurosciences, surgery and organ transplants. The company was founded in 1956 and is headquartered in Stanford, CA. | Health Services |
Merck Research Laboratories Massachusetts LLC
![]() Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
Roche Global Development |
- Borsa valori
- Insiders
- David Karpf
- Esperienza